Synapse

← Matthias Egger

Papers by Matthias Egger

Page 7 · newest first

  1. Challenges in assessing the sunscreen‐melanoma associationInternational Journal of Cancer · 2018
  2. The contribution of observational studies in supporting the WHO 'treat all' recommendation for HIV/AIDS.2018
  3. Importance of routine viral load monitoring: higher levels of resistance at ART failure in Uganda and Lesotho compared with SwitzerlandJournal of Antimicrobial Chemotherapy · 2018
  4. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiationJournal of the International AIDS Society · 2018
  5. IeDEA–WHO Research-Policy Collaboration: contributing real-world evidence to HIV progress reporting and guideline developmentJournal of Virus Eradication · 2018
  6. HIV drug resistance in sub-Saharan Africa: public health questions and the potential role of real-world data and mathematical modellingJournal of Virus Eradication · 2018
  7. The contribution of observational studies in supporting the WHO ‘treat all’ recommendation for HIV/AIDSJournal of Virus Eradication · 2018
  8. Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-AnalysisFOCUS The Journal of Lifelong Learning in Psychiatry · 2018
  9. Virologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysisF1000Research · 2018
  10. What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management StrategiesThe Pediatric Infectious Disease Journal · 2018
  11. Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries2018
  12. Planning a future randomized clinical trial based on a network of relevant past trialsTrials · 2018
  13. Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort StudyVirus Evolution · 2018
  14. High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus–coinfected Men Who Have Sex With MenClinical Infectious Diseases · 2018
  15. Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort StudyOpen Forum Infectious Diseases · 2018
  16. Estimating the contribution of studies in network meta-analysis: paths, flows and streamsF1000Research · 2018
  17. Planning a future randomized clinical trial based on a network of relevant past trials2018
  18. Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysisClinical Infectious Diseases · 2018
  19. Lest we forget, primary health care in Sub-Saharan Africa is nurse led. Is this reflected in the current health systems strengthening undertakings and initiatives?Journal of Global Health Reports · 2018
  20. The Cumulative Impact of Harm Reduction on the Swiss HIV Epidemic: Cohort Study, Mathematical Model, and Phylogenetic AnalysisOpen Forum Infectious Diseases · 2018
  21. Impact of placebo arms on outcomes in antidepressant trials: systematic review and meta-regression analysisInternational Journal of Epidemiology · 2018
  22. No Impact of Hepatitis B Virus Infection on Early Mortality Among Human Immunodeficiency Virus–Infected Patients in Southern AfricaClinical Infectious Diseases · 2018
  23. Antidepressants might work for people with major depression: where do we go from here?The Lancet Psychiatry · 2018
  24. Strengthening Routine Data Systems to Track the HIV Epidemic and Guide the Response in Sub-Saharan AfricaJMIR Public Health and Surveillance · 2018
  25. Dietary Patterns and Physical Activity Correlate With Total Cholesterol Independently of Lipid-Lowering Drugs and Antiretroviral Therapy in Aging People Living With Human Immunodeficiency VirusOpen Forum Infectious Diseases · 2018
  26. Death at no cost? Persons with no health insurance claims in the last year of life in SwitzerlandBMC Health Services Research · 2018
  27. CPAP as treatment of sleep apnea after strokeNeurology · 2018
  28. No Effect of Pegylated Interferon-α on Total HIV-1 DNA Load in HIV-1/HCV Coinfected PatientsThe Journal of Infectious Diseases · 2018
  29. Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical studyBMJ · 2018
  30. Developing WHO guidelines: Time to formally include evidence from mathematical modelling studiesF1000Research · 2018
  31. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysisThe Lancet · 2018
  32. Retention and mortality on antiretroviral therapy in sub‐Saharan Africa: collaborative analyses of HIV treatment programmesJournal of the International AIDS Society · 2018
  33. HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in ZimbabweOpen Forum Infectious Diseases · 2018
  34. Seasonal variations in tuberculosis diagnosis among HIV-positive individuals in Southern Africa: analysis of cohort studies at antiretroviral treatment programmesBMJ Open · 2018
  35. Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling studyPLoS Medicine · 2017
  36. A model for meta-analysis of correlated binary outcomes: The case of split-body interventionsStatistical Methods in Medical Research · 2017
  37. Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment ProgramsClinical Infectious Diseases · 2017
  38. Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistanceAIDS · 2017
  39. Long-term Immune Response to Yellow Fever Vaccination in Human Immunodeficiency Virus (HIV)–Infected Individuals Depends on HIV RNA Suppression Status: Implications for Vaccination ScheduleClinical Infectious Diseases · 2017
  40. Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan AfricaBMC Infectious Diseases · 2017
  41. Rheumatoid arthritis patients treated in trial and real world settings: comparison of randomized trials with registriesLara D. Veeken · 2017
  42. High Rates of Subsequent Asymptomatic Sexually Transmitted Infections and Risky Sexual Behavior in Patients Initially Presenting With Primary Human Immunodeficiency Virus-1 InfectionClinical Infectious Diseases · 2017
  43. Survival of patients with Kaposi’s sarcoma in the South African antiretroviral treatment era: A retrospective cohort studySouth African Medical Journal · 2017
  44. Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysiseLife · 2017
  45. Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan AfricaBMC Cancer · 2017
  46. Perspective: An Extension of the STROBE Statement for Observational Studies in Nutritional Epidemiology (STROBE-nut): Explanation and ElaborationAdvances in Nutrition · 2017
  47. Developing WHO guidelines: Time to formally include evidence from mathematical modelling studiesF1000Research · 2017
  48. The HIV Care Cascade from HIV diagnosis to viral suppression in sub-Saharan Africa: a systematic review and meta-regression analysis protocolSystematic Reviews · 2017
  49. Series: Pragmatic trials and real world evidence: Paper 8. Data collection and managementJournal of Clinical Epidemiology · 2017
  50. The cascade of care to prevent mother‐to‐child transmission in Rio de Janeiro, Brazil, 1996–2013: improving but still some way to goTropical Medicine & International Health · 2017